Microbial biofilms: Impact on the pathogenesis of periodontitis, cystic fibrosis, chronic wounds and medical device-related infections

Current Topics in Medicinal Chemistry

Volumn 15, Issue 16, 2015, Pages 1552-1576

  Mihai, Mara Mădălina ^a   Holban, Alina Maria ^b   Giurcăneanu, Călin ^a   Popa, Liliana Gabriela ^a   Oanea, Raluca Mihaela ^c   Lazăr, Veronica ^b   Chifiriuc, Mariana Carmen ^b   Popa, Marcela ^c   Popa, Mircea Ioan ^a  

^a CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^b UNIVERSITY OF BUCHAREST   (Romania)

^c HOSPITAL DEL MAR   (Spain)

Author keywords

Biofilm diagnosis; Biofilm formation; Biofilm resistance; Experimental models; Human microbiota; Tolerance

Indexed keywords

ARTICLE; ATHEROSCLEROSIS; BIOFILM; CARDIOVASCULAR DISEASE; CHRONIC WOUND; CYSTIC FIBROSIS; DEVICE INFECTION; DIABETES MELLITUS; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; LUNG INFECTION; NONHUMAN; PERIODONTITIS; PHAGOCYTOSIS; POLYMERASE CHAIN REACTION; PSEUDOMONAS AERUGINOSA; QUALITY OF LIFE; QUORUM SENSING; SPATIOTEMPORAL ANALYSIS; DRUG EFFECTS; GROWTH, DEVELOPMENT AND AGING; MICROBIOLOGY; MICROFLORA; MULTIDRUG RESISTANCE; PROSTHESIS-RELATED INFECTIONS; WOUNDS AND INJURIES;

ANTIINFECTIVE AGENT;

ANTI-BACTERIAL AGENTS; BIOFILMS; CYSTIC FIBROSIS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; MICROBIOTA; PERIODONTITIS; PROSTHESIS-RELATED INFECTIONS; WOUNDS AND INJURIES;

EID: 84930901595     PISSN: 15680266     EISSN: 18734294     Source Type: Journal    
DOI: 10.2174/1568026615666150414123800     Document Type: Article

References (328)

1. Hall-Stoodley, L.; Stoodley, P.; Kathju, S.; Hoiby, N.; Moser, C.; Costerton, J. W.; Moter, A.; Bjarnsholt, T. Towards diagnostic guidelines for biofilm-associated infections. FEMS Immunol. Med. Microbiol., 2012, 65(2), 127-45.
2. Alhede, M.; Kragh, K. N.; Qvortrup, K.; Allesen-Holm, M.; van Gennip, M.; Christensen, L. D.; Jensen, P. O.; Nielsen, A. K.; Parsek, M.; Wozniak, D.; Molin, S.; Tolker-Nielsen, T.; Hoiby, N.; Givskov, M.; Bjarnsholt, T. Phenotypes of non-attached Pseudomonas aeruginosa aggregates resemble surface attached biofilm. PLoS One, 2011, 6(11), e27943.
3. Pezzoni, M.; Pizarro, R. A.; Costa, C. S. Protective role of extracellular catalase (KatA) against UVA radiation in Pseudomonas aeruginosa biofilms. J. Photochem. Photobiol. B., 2014, 131, 53-64.
4. Ishak, N.; Tikhomirova, A.; Bent, S. J.; Ehrlich, G. D.; Hu, F. Z.; Kidd, S. P. There is a specific response to pH by isolates of Haemophilus influenzae and this has a direct influence on biofilm formation. BMC Microbiol., 2014, 14, 47.
5. Domenech, M.; Ramos-Sevillano, E.; Garcia, E.; Moscoso, M.; Yuste, J. Biofilm formation avoids complement immunity and phagocytosis of Streptococcus pneumoniae. Infect. Immun., 2013, 81(7), 2606-15.
6. Nusbaum, A. G.; Kirsner, R. S.; Charles, C. A. Biofilms in dermatology. Skin Therapy Lett., 2012, 17(7), 1-5.
7. Darouiche, R. O. Treatment of infections associated with surgical implants. N. Engl. J. Med., 2004, 350(14), 1422-9.
8. Hall-Stoodley, L.; Costerton, J. W.; Stoodley, P. Bacterial biofilms: from the natural environment to infectious diseases. Nat. Rev. Microbiol., 2004, 2(2), 95-108.
9. Hoiby, N.; Bjarnsholt, T.; Givskov, M.; Molin, S.; Ciofu, O. Antibiotic resistance of bacterial biofilms. Int. J. Antimicrob. Agents, 2010, 35(4), 322-32.
10. Flemming, H. C.; Wingender, J. The biofilm matrix. Nat. Rev. Microbiol., 2010, 8(9), 623-33.
11. Wolcott, R. D.; Rhoads, D. D.; Bennett, M. E.; Wolcott, B. M.; Gogokhia, L.; Costerton, J. W.; Dowd, S. E. Chronic wounds and the medical biofilm paradigm. J. Wound Care, 2010, 19(2), 45-6, 48-50, 52-3.
12. Anderson, G. G.; O'Toole, G. A. Innate and induced resistance mechanisms of bacterial biofilms. Curr. Top. Microbiol. Immunol., 2008, 322, 85-105.
13. Bjarnsholt, T. The role of bacterial biofilms in chronic infections. APMIS Suppl., 2013, (136), 1-51.
14. Costerton, J. W.; Stewart, P. S.; Greenberg, E. P. Bacterial biofilms: a common cause of persistent infections. Science, 1999, 284(5418), 1318-22.
15. Jefferson, K. K.; Goldmann, D. A.; Pier, G. B. Use of confocal microscopy to analyze the rate of vancomycin penetration through Staphylococcus aureus biofilms. Antimicrob. Agents Chemother., 2005, 49(6), 2467-73.
16. Bagge, N.; Hentzer, M.; Andersen, J. B.; Ciofu, O.; Givskov, M.; Hoiby, N. Dynamics and spatial distribution of beta-lactamase expression in Pseudomonas aeruginosa biofilms. Antimicrob. Agents Chemother., 2004, 48(4), 1168-74.
17. Fux, C. A.; Wilson, S.; Stoodley, P. Detachment characteristics and oxacillin resistance of Staphyloccocus aureus biofilm emboli in an in vitro catheter infection model. J. Bacteriol., 2004, 186(14), 4486-91.
18. Ceri, H.; Olson, M. E.; Turner, R. J. Needed, new paradigms in antibiotic development. Expert Opin. Pharmacother., 2010, 11(8), 1233-7.
19. Anwar, H.; Costerton, J. W. Enhanced activity of combination of tobramycin and piperacillin for eradication of sessile biofilm cells of Pseudomonas aeruginosa. Antimicrob. Agents Chemother., 1990, 34(9), 1666-71.
20. Moskowitz, S. M.; Foster, J. M.; Emerson, J.; Burns, J. L. Clinically feasible biofilm susceptibility assay for isolates of Pseudomonas aeruginosa from patients with cystic fibrosis. J. Clin. Microbiol., 2004, 42(5), 1915-22.
21. Bjarnsholt, T.; Kirketerp-Moller, K.; Kristiansen, S.; Phipps, R.; Nielsen, A. K.; Jensen, P. O.; Hoiby, N.; Givskov, M. Silver against Pseudomonas aeruginosa biofilms. APMIS, 2007, 115(8), 921-8.
22. Driffield, K.; Miller, K.; Bostock, J. M.; O'Neill, A. J.; Chopra, I. Increased mutability of Pseudomonas aeruginosa in biofilms. J. Antimicrob. Chemother., 2008, 61(5), 1053-6.
23. Tolker-Nielsen, T. Pseudomonas aeruginosa biofilm infections: from molecular biofilm biology to new treatment possibilities. APMIS Suppl., 2014, (138), 1-51.
24. Trampuz, A.; Zimmerli, W. Diagnosis and treatment of implantassociated septic arthritis and osteomyelitis. Curr. Infect. Dis. Rep., 2008, 10(5), 394-403.
25. Hoiby, N.; Frederiksen, B.; Pressler, T. Eradication of early Pseudomonas aeruginosa infection. J. Cyst. Fibros., 2005, 4 Suppl 2, 49-54.
26. Rosen, D. A.; Pinkner, J. S.; Jones, J. M.; Walker, J. N.; Clegg, S.; Hultgren, S. J. Utilization of an intracellular bacterial community pathway in Klebsiella pneumoniae urinary tract infection and the effects of FimK on type 1 pilus expression. Infect. Immun., 2008, 76(7), 3337-45.
27. Goller, C. C.; Seed, P. C. Revisiting the Escherichia coli polysaccharide capsule as a virulence factor during urinary tract infection: contribution to intracellular biofilm development. Virulence, 2010, 1(4), 333-7.
28. Robino, L.; Scavone, P.; Araujo, L.; Algorta, G.; Zunino, P.; Vignoli, R. Detection of intracellular bacterial communities in a child with Escherichia coli recurrent urinary tract infections. Pathog. Dis., 2013, 68(3), 78-81.
29. Robino, L.; Scavone, P.; Araujo, L.; Algorta, G.; Zunino, P.; Pirez, M. C.; Vignoli, R. Intracellular bacteria in the pathogenesis of Escherichia coli urinary tract infection in children. Clin. Infect. Dis., 2014, 59(11), e158-64.
30. Tan, N. C.; Foreman, A.; Jardeleza, C.; Douglas, R.; Tran, H.; Wormald, P. J. The multiplicity of Staphylococcus aureus in chronic rhinosinusitis: correlating surface biofilm and intracellular residence. Laryngoscope, 2012, 122(8), 1655-60.
31. Ciofu, O.; Tolker-Nielsen, T.; Jensen, P. O.; Wang, H.; Hoiby, N. Antimicrobial resistance, respiratory tract infections and role of biofilms in lung infections in cystic fibrosis patients. Adv. Drug. Deliv. Rev., 2014.
32. Egland, P. G.; Palmer, R. J., Jr.; Kolenbrander, P. E. Interspecies communication in Streptococcus gordonii-Veillonella atypica biofilms: signaling in flow conditions requires juxtaposition. Proc. Natl. Acad. Sci. U. S. A., 2004, 101(48), 16917-22.
33. Marshall, K. C. Biofilms: an overview of bacterial adhesion, activity, and control at surfaces. ASM News, 1992, 58: 202-7.
34. Hengge, R. Principles of c-di-GMP signalling in bacteria. Nat. Rev. Microbiol., 2009, 7(4), 263-73.
35. Whiteley, C. G.; Lee, D. J. Bacterial diguanylate cyclases: Structure, function and mechanism in exopolysaccharide biofilm development. Biotechnol. Adv., 2015, 33(1): 124-41.
36. Whitchurch, C. B.; Tolker-Nielsen, T.; Ragas, P. C.; Mattick, J. S. Extracellular DNA required for bacterial biofilm formation. Science, 2002, 295(5559), 1487.
37. Klausen, M.; Heydorn, A.; Ragas, P.; Lambertsen, L.; Aaes-Jorgensen, A.; Molin, S.; Tolker-Nielsen, T. Biofilm formation by Pseudomonas aeruginosa wild type, flagella and type IV pili mutants. Mol. Microbiol., 2003, 48(6), 1511-24.
38. Guttenplan, S. B.; Blair, K. M.; Kearns, D. B. The EpsE flagellar clutch is bifunctional and synergizes with EPS biosynthesis to promote Bacillus subtilis biofilm formation. PLoS Genet., 2010, 6(12), e1001243.
39. Guttenplan, S. B.; Shaw, S.; Kearns, D. B. The cell biology of peritrichous flagella in Bacillus subtilis. Mol. Microbiol., 2013, 87(1), 211-29.
40. Yildiz, F. H.; Visick, K. L. Vibrio biofilms: so much the same yet so different. Trends Microbiol., 2009, 17(3), 109-18.
41. Wood, T. K.; Gonzalez Barrios, A. F.; Herzberg, M.; Lee, J. Motility influences biofilm architecture in Escherichia coli. Appl. Microbiol. Biotechnol., 2006, 72(2), 361-7.
42. Guttenplan, S. B.; Kearns, D. B. Regulation of flagellar motility during biofilm formation. FEMS Microbiol. Rev., 2013, 37(6), 849-71.
43. Klausen, M.; Aaes-Jorgensen, A.; Molin, S.; Tolker-Nielsen, T. Involvement of bacterial migration in the development of complex multicellular structures in Pseudomonas aeruginosa biofilms. Mol. Microbiol., 2003, 50(1), 61-8.
44. Wei, Q.; Ma, L. Z. Biofilm matrix and its regulation in Pseudomonas aeruginosa. Int. J. Mol. Sci., 2013, 14(10), 20983-1005.
45. Colvin, K. M.; Irie, Y.; Tart, C. S.; Urbano, R.; Whitney, J. C.; Ryder, C.; Howell, P. L.; Wozniak, D. J.; Parsek, M. R. The Pel and Psl polysaccharides provide Pseudomonas aeruginosa structural redundancy within the biofilm matrix. Environ. Microbiol., 2012, 14(8), 1913-28.
46. Costa, A. R.; Henriques, M.; Oliveira, R.; Azeredo, J. The role of polysaccharide intercellular adhesin (PIA) in Staphylococcus epidermidis adhesion to host tissues and subsequent antibiotic tolerance. Eur. J. Clin. Microbiol. Infect. Dis., 2009, 28(6), 623-9.
47. Shiro, H.; Meluleni, G.; Groll, A.; Muller, E.; Tosteson, T. D.; Goldmann, D. A.; Pier, G. B. The pathogenic role of Staphylococcus epidermidis capsular polysaccharide/adhesin in a low-inoculum rabbit model of prosthetic valve endocarditis. Circulation, 1995, 92(9), 2715-22.
48. Cramton, S. E.; Gerke, C.; Schnell, N. F.; Nichols, W. W.; Gotz, F. The intercellular adhesion (ica) locus is present in Staphylococcus aureus and is required for biofilm formation. Infect. Immun., 1999, 67(10), 5427-33.
49. Foulston, L.; Elsholz, A. K.; DeFrancesco, A. S.; Losick, R. The extracellular matrix of Staphylococcus aureus biofilms comprises cytoplasmic proteins that associate with the cell surface in response to decreasing pH. MBio., 2014, 5(5), e01667-14.
50. Rice, K. C.; Mann, E. E.; Endres, J. L.; Weiss, E. C.; Cassat, J. E.; Smeltzer, M. S.; Bayles, K. W. The cidA murein hydrolase regulator contributes to DNA release and biofilm development in Staphylococcus aureus. Proc. Natl. Acad. Sci. U. S. A., 2007, 104(19), 8113-8.
51. Allesen-Holm, M.; Barken, K. B.; Yang, L.; Klausen, M.; Webb, J. S.; Kjelleberg, S.; Molin, S.; Givskov, M.; Tolker-Nielsen, T. A characterization of DNA release in Pseudomonas aeruginosa cultures and biofilms. Mol. Microbiol., 2006, 59(4), 1114-28.
52. Parks, Q. M.; Young, R. L.; Poch, K. R.; Malcolm, K. C.; Vasil, M. L.; Nick, J. A. Neutrophil enhancement of Pseudomonas aeruginosa biofilm development: human F-actin and DNA as targets for therapy. J. Med. Microbiol., 2009, 58(Pt 4), 492-502.
53. Chiang, W. C.; Nilsson, M.; Jensen, P. O.; Hoiby, N.; Nielsen, T. E.; Givskov, M.; Tolker-Nielsen, T. Extracellular DNA shields against aminoglycosides in Pseudomonas aeruginosa biofilms. Antimicrob. Agents Chemother., 2013, 57(5), 2352-61.
54. Montanaro, L.; Poggi, A.; Visai, L.; Ravaioli, S.; Campoccia, D.; Speziale, P.; Arciola, C. R. Extracellular DNA in biofilms. Int. J. Artif. Organs, 2011, 34(9), 824-31.
55. Kolenbrander, P. E.; Palmer, R. J., Jr.; Periasamy, S.; Jakubovics, N. S. Oral multispecies biofilm development and the key role of cell-cell distance. Nat. Rev. Microbiol., 2010, 8(7), 471-80.
56. Juhas, M.; Eberl, L.; Tummler, B. Quorum sensing: the power of cooperation in the world of Pseudomonas. Environ. Microbiol., 2005, 7(4), 459-71.
57. Hardie, K. R.; Heurlier, K. Establishing bacterial communities by 'word of mouth': LuxS and autoinducer 2 in biofilm development. Nat. Rev. Microbiol., 2008, 6(8), 635-43.
58. Costerton, J. W.; Lewandowski, Z.; Caldwell, D. E.; Korber, D. R.; Lappin-Scott, H. M. Microbial biofilms. Annu. Rev. Microbiol., 1995, 49, 711-45.
59. Werner, E.; Roe, F.; Bugnicourt, A.; Franklin, M. J.; Heydorn, A.; Molin, S.; Pitts, B.; Stewart, P. S. Stratified growth in Pseudomonas aeruginosa biofilms. Appl. Environ. Microbiol., 2004, 70(10), 6188-96.
60. Keren, I.; Kaldalu, N.; Spoering, A.; Wang, Y.; Lewis, K. Persister cells and tolerance to antimicrobials. FEMS Microbiol. Lett., 2004, 230(1), 13-8.
61. Hodl, I.; Mari, L.; Bertuzzo, E.; Suweis, S.; Besemer, K.; Rinaldo, A.; Battin, T. J. Biophysical controls on cluster dynamics and architectural differentiation of microbial biofilms in contrasting flow environments. Environ. Microbiol., 2014, 16(3), 802-12.
62. Schleheck, D.; Barraud, N.; Klebensberger, J.; Webb, J. S.; McDougald, D.; Rice, S. A.; Kjelleberg, S. Pseudomonas aeruginosa PAO1 preferentially grows as aggregates in liquid batch cultures and disperses upon starvation. PLoS One, 2009, 4(5), e5513.
63. Donlan, R. M.; Costerton, J. W. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin. Microbiol. Rev., 2002, 15(2), 167-93.
64. Van Acker, H.; Sass, A.; Bazzini, S.; De Roy, K.; Udine, C.; Messiaen, T.; Riccardi, G.; Boon, N.; Nelis, H. J.; Mahenthiralingam, E.; Coenye, T. Biofilm-grown Burkholderia cepacia complex cells survive antibiotic treatment by avoiding production of reactive oxygen species. PLoS One, 2013, 8(3), e58943.
65. Stoodley, P.; Cargo, R.; Rupp, C. J.; Wilson, S.; Klapper, I. Biofilm material properties as related to shear-induced deformation and detachment phenomena. J. Ind. Microbiol. Biotechnol., 2002, 29(6), 361-7.
66. Kaplan, J. B. Biofilm dispersal: mechanisms, clinical implications, and potential therapeutic uses. J. Dent. Res., 2010, 89(3), 205-18.
67. Rowe, M. C.; Withers, H. L.; Swift, S. Uropathogenic Escherichia coli forms biofilm aggregates under iron restriction that disperse upon the supply of iron. FEMS Microbiol. Lett., 2010, 307(1), 102-9.
68. Kostakioti, M.; Hadjifrangiskou, M.; Hultgren, S. J. Bacterial biofilms: development, dispersal, and therapeutic strategies in the dawn of the postantibiotic era. Cold Spring Harb. Perspect. Med., 2013, 3(4), a010306.
69. Gjermansen, M.; Ragas, P.; Sternberg, C.; Molin, S.; Tolker-Nielsen, T. Characterization of starvation-induced dispersion in Pseudomonas putida biofilms. Environ. Microbiol., 2005, 7(6), 894-906.
70. Chua, S. L.; Liu, Y.; Yam, J. K.; Chen, Y.; Vejborg, R. M.; Tan, B. G.; Kjelleberg, S.; Tolker-Nielsen, T.; Givskov, M.; Yang, L. Dispersed cells represent a distinct stage in the transition from bacterial biofilm to planktonic lifestyles. Nat. Commun., 2014, 5, 4462.
71. Roby, B. B.; McNamara, J.; Finkelstein, M.; Sidman, J. Sinus surgery in cystic fibrosis patients: comparison of sinus and lower airway cultures. Int. J. Pediatr. Otorhinolaryngol., 2008, 72(9), 1365-9.
72. Solano, C.; Echeverz, M.; Lasa, I. Biofilm dispersion and quorum sensing. Curr. Opin. Microbiol., 2014, 18, 96-104.
73. Barraud, N.; Schleheck, D.; Klebensberger, J.; Webb, J. S.; Hassett, D. J.; Rice, S. A.; Kjelleberg, S. Nitric oxide signaling in Pseudomonas aeruginosa biofilms mediates phosphodiesterase activity, decreased cyclic di-GMP levels, and enhanced dispersal. J. Bacteriol., 2009, 191(23), 7333-42.
74. Wood, T. K.; Hong, S. H.; Ma, Q. Engineering biofilm formation and dispersal. Trends Biotechnol., 2011, 29(2), 87-94.
75. Lamppa, J. W.; Griswold, K. E. Alginate lyase exhibits catalysisindependent biofilm dispersion and antibiotic synergy. Antimicrob. Agents Chemother., 2013, 57(1), 137-45.
76. Farrell, E. K.; Tipton, P. A. Functional characterization of AlgL, an alginate lyase from Pseudomonas aeruginosa. Biochemistry, 2012, 51(51), 10259-66.
77. Zielinska, A. K.; Beenken, K. E.; Mrak, L. N.; Spencer, H. J.; Post, G. R.; Skinner, R. A.; Tackett, A. J.; Horswill, A. R.; Smeltzer, M. S. sarA-mediated repression of protease production plays a key role in the pathogenesis of Staphylococcus aureus USA300 isolates. Mol. Microbiol., 2012, 86(5), 1183-96.
78. Donelli, G.; Francolini, I.; Romoli, D.; Guaglianone, E.; Piozzi, A.; Ragunath, C.; Kaplan, J. B. Synergistic activity of dispersin B and cefamandole nafate in inhibition of staphylococcal biofilm growth on polyurethanes. Antimicrob. Agents Chemother., 2007, 51(8), 2733-40.
79. Lister, J. L.; Horswill, A. R. Staphylococcus aureus biofilms: recent developments in biofilm dispersal. Front. Cell. Infect. Microbiol., 2014, 4, 178.
80. Harmsen, M.; Yang, L.; Pamp, S. J.; Tolker-Nielsen, T. An update on Pseudomonas aeruginosa biofilm formation, tolerance, and dispersal. FEMS Immunol. Med. Microbiol., 2010, 59(3), 253-68.
81. Peschel, A.; Otto, M. Phenol-soluble modulins and staphylococcal infection. Nat. Rev. Microbiol., 2013, 11(10), 667-73.
82. Kolodkin-Gal, I.; Romero, D.; Cao, S.; Clardy, J.; Kolter, R.; Losick, R. D-amino acids trigger biofilm disassembly. Science, 2010, 328(5978), 627-9.
83. Purevdorj-Gage, B.; Costerton, W. J.; Stoodley, P. Phenotypic differentiation and seeding dispersal in non-mucoid and mucoid Pseudomonas aeruginosa biofilms. Microbiology, 2005, 151(Pt 5), 1569-76.
84. Stoodley, P.; Lewandowski, Z.; Boyle, J. D.; Lappin-Scott, H. M. The formation of migratory ripples in a mixed species bacterial biofilm growing in turbulent flow. Environ. Microbiol., 1999, 1(5), 447-55.
85. Parsek, M. R.; Singh, P. K. Bacterial biofilms: an emerging link to disease pathogenesis. Annu. Rev. Microbiol., 2003, 57, 677-701.
86. Hall-Stoodley, L.; Stoodley, P. Evolving concepts in biofilm infections. Cell. Microbiol., 2009, 11(7), 1034-43.
87. Hoiby, N.; Bjarnsholt, T.; Moser, C.; Bassi, G. L.; Coenye, T.; Donelli, G.; Hall-Stoodley, L.; Hola, V.; Imbert, C.; Kirketerp-Moller, K.; Lebeaux, D.; Oliver, A.; Ullmann, A. J.; Williams, C.; Biofilms, E. S. G. f.; Consulting External Expert Werner, Z. ESCMID guideline for the diagnosis and treatment of biofilm infections 2014. Clin. Microbiol. Infect., 2015, (ahead of print): 1-25.
88. Pressler, T.; Karpati, F.; Granstrom, M.; Knudsen, P. K.; Lindblad, A.; Hjelte, L.; Olesen, H. V.; Meyer, P.; Hoiby, N.; Scandinavian, C. F. S. C. Diagnostic significance of measurements of specific IgG antibodies to Pseudomonas aeruginosa by three different serological methods. J. Cyst. Fibros., 2009, 8(1), 37-42.
89. Kobayashi, N.; Bauer, T. W.; Tuohy, M. J.; Fujishiro, T.; Procop, G. W. Brief ultrasonication improves detection of biofilmformative bacteria around a metal implant. Clin. Orthop. Relat. Res., 2007, 457, 210-3.
90. Ceri, H.; Olson, M.; Morck, D.; Storey, D.; Read, R.; Buret, A.; Olson, B. The MBEC Assay System: multiple equivalent biofilms for antibiotic and biocide susceptibility testing. Methods Enzymol., 2001, 337, 377-85.
91. Parker, A. E.; Walker, D. K.; Goeres, D. M.; Allan, N.; Olson, M. E.; Omar, A. Ruggedness and reproducibility of the MBEC biofilm disinfectant efficacy test. J. Microbiol. Methods, 2014, 102, 55-64.
92. Bjarnsholt, T.; Kirketerp-Moller, K.; Jensen, P. O.; Madsen, K. G.; Phipps, R.; Krogfelt, K.; Hoiby, N.; Givskov, M. Why chronic wounds will not heal: a novel hypothesis. Wound Repair Regen., 2008, 16(1), 2-10.
93. Kirketerp-Moller, K.; Jensen, P. O.; Fazli, M.; Madsen, K. G.; Pedersen, J.; Moser, C.; Tolker-Nielsen, T.; Hoiby, N.; Givskov, M.; Bjarnsholt, T. Distribution, organization, and ecology of bacteria in chronic wounds. J. Clin. Microbiol., 2008, 46(8), 2717-22.
94. Akers, K. S.; Cardile, A. P.; Wenke, J. C.; Murray, C. K. Biofilm formation by clinical isolates and its relevance to clinical infections. Adv. Exp. Med. Biol., 2015, 830: 1-28.
95. Romling, U.; Balsalobre, C. Biofilm infections, their resilience to therapy and innovative treatment strategies. J. Intern. Med., 2012, 272(6), 541-61.
96. Rhoads, D. D.; Wolcott, R. D.; Sun, Y.; Dowd, S. E. Comparison of culture and molecular identification of bacteria in chronic wounds. Int. J. Mol. Sci., 2012, 13(3), 2535-50.
97. Richards, M. J.; Edwards, J. R.; Culver, D. H.; Gaynes, R. P. Nosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System. Crit. Care Med., 1999, 27(5), 887-92.
98. Kobayashi, H. Airway biofilms: implications for pathogenesis and therapy of respiratory tract infections. Treat. Respir. Med., 2005, 4(4), 241-53.
99. Pintucci, J. P.; Corno, S.; Garotta, M. Biofilms and infections of the upper respiratory tract. Eur. Rev. Med. Pharmacol. Sci., 2010, 14(8), 683-90.
100. Anderson, G. G.; Palermo, J. J.; Schilling, J. D.; Roth, R.; Heuser, J.; Hultgren, S. J. Intracellular bacterial biofilm-like pods in urinary tract infections. Science, 2003, 301(5629), 105-7.
101. Nickel, J. C.; Olson, M. E.; Barabas, A.; Benediktsson, H.; Dasgupta, M. K.; Costerton, J. W. Pathogenesis of chronic bacterial prostatitis in an animal model. Br. J. Urol., 1990, 66(1), 47-54.
102. Zhang, X.; Sun, X.; Wang, Z.; Zhang, Y.; Hou, W. Keratitisassociated fungi form biofilms with reduced antifungal drug susceptibility. Invest. Ophthalmol. Vis. Sci., 2012, 53(12), 7774-8.
103. Gil-Perotin, S.; Ramirez, P.; Marti, V.; Sahuquillo, J. M.; Gonzalez, E.; Calleja, I.; Menendez, R.; Bonastre, J. Implications of endotracheal tube biofilm in ventilator-associated pneumonia response: a state of concept. Crit. Care, 2012, 16(3), R93.
104. Inglis, T. J.; Lim, T. M.; Ng, M. L.; Tang, E. K.; Hui, K. P. Structural features of tracheal tube biofilm formed during prolonged mechanical ventilation. Chest, 1995, 108(4), 1049-52.
105. Friedland, D. R.; Rothschild, M. A.; Delgado, M.; Isenberg, H.; Holzman, I. Bacterial colonization of endotracheal tubes in intubated neonates. Arch. Otolaryngol. Head Neck Surg., 2001, 127(5), 525-8.
106. Mermel, L. A.; Allon, M.; Bouza, E.; Craven, D. E.; Flynn, P.; O'Grady, N. P.; Raad, II; Rijnders, B. J.; Sherertz, R. J.; Warren, D. K. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. Clin. Infect. Dis., 2009, 49(1), 1-45.
107. Conway, L. J.; Larson, E. L. Guidelines to prevent catheterassociated urinary tract infection: 1980 to 2010. Heart Lung, 2012, 41(3), 271-83.
108. Hooton, T. M.; Bradley, S. F.; Cardenas, D. D.; Colgan, R.; Geerlings, S. E.; Rice, J. C.; Saint, S.; Schaeffer, A. J.; Tambayh, P. A.; Tenke, P.; Nicolle, L. E. Infectious Diseases Society of, A.; Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America. Clin. Infect. Dis., 2010, 50(5), 625-63.
109. Fulcher, T. P.; Dart, J. K.; McLaughlin-Borlace, L.; Howes, R.; Matheson, M.; Cree, I. Demonstration of biofilm in infectious crystalline keratopathy using ruthenium red and electron microscopy. Ophthalmology, 2001, 108(6), 1088-92.
110. Balikoglu-Yilmaz, M.; Yilmaz, T.; Cetinel, S.; Taskin, U.; Banu Esen, A.; Taskapili, M.; Kose, T. Comparison of scanning electron microscopy findings regarding biofilm colonization with microbiological results in nasolacrimal stents for external, endoscopic and transcanalicular dacryocystorhinostomy. Int. J. Ophthalmol., 2014, 7(3), 534-40.
111. Christensen, L.; Breiting, V.; Bjarnsholt, T.; Eickhardt, S.; Hogdall, E.; Janssen, M.; Pallua, N.; Zaat, S. A. Bacterial infection as a likely cause of adverse reactions to polyacrylamide hydrogel fillers in cosmetic surgery. Clin. Infect. Dis., 2013, 56(10), 1438-44.
112. Bjarnsholt, T.; Tolker-Nielsen, T.; Givskov, M.; Janssen, M.; Christensen, L. H. Detection of bacteria by fluorescence in situ hybridization in culture-negative soft tissue filler lesions. Dermatol. Surg., 2009, 35 Suppl 2, 1620-4.
113. Gristina, A. G.; Costerton, J. W. Bacterial adherence to biomaterials and tissue. The significance of its role in clinical sepsis. J. Bone Joint Surg. Am., 1985, 67(2), 264-73.
114. Rieger, U. M.; Mesina, J.; Kalbermatten, D. F.; Haug, M.; Frey, H. P.; Pico, R.; Frei, R.; Pierer, G.; Luscher, N. J.; Trampuz, A. Bacterial biofilms and capsular contracture in patients with breast implants. Br. J. Surg., 2013, 100(6), 768-74.
115. Darouiche, R. O. Device-associated infections: a macroproblem that starts with microadherence. Clin. Infect. Dis., 2001, 33(9), 1567-72.
116. Krom, B. P.; Oskam, J. Microbial biofilms and wound healing: an ecological hypothesis. Phlebology, 2014, 29(1 suppl), 168-173.
117. Dye, B. A.; Barker, L. K.; Li, X.; Lewis, B. G.; Beltran-Aguilar, E. D. Overview and quality assurance for the oral health component of the National Health and Nutrition Examination Survey (NHANES), 2005-08. J. Public. Health Dent., 2011, 71(1), 54-61.
118. Better Oral Health European Platform. Facts and Figures-The State of Oral health in Europe. (2012): Available from: http://www. oralhealthplatform. eu/sites/default/files/field/document/Factsheet_oral health in Europe_2012_0. pdf (Accessed Feb 13, 2015).
119. World Health Organisation. Oral Health: Available from: http://www. who. int/oral_health/disease_burden/global/en/(Accessed Feb 13, 2015).
120. Chen, T.; Yu, W. H.; Izard, J.; Baranova, O. V.; Lakshmanan, A.; Dewhirst, F. E. The Human Oral Microbiome Database: a web accessible resource for investigating oral microbe taxonomic and genomic information. Database (Oxford), 2010, 2010, baq013.
121. Zaura, E.; Keijser, B. J.; Huse, S. M.; Crielaard, W. Defining the healthy "core microbiome" of oral microbial communities. BMC Microbiol., 2009, 9, 259.
122. Hu, Y. J.; Shao, Z. Y.; Wang, Q.; Jiang, Y. T.; Ma, R.; Tang, Z. S.; Liu, Z.; Liang, J. P.; Huang, Z. W. Exploring the dynamic core microbiome of plaque microbiota during head-and-neck radiotherapy using pyrosequencing. PLoS One, 2013, 8(2), e56343.
123. Abiko, Y.; Saitoh, M. Salivary defensins and their importance in oral health and disease. Curr. Pharm. Des., 2007, 13(30), 3065-72.
124. Socransky, S. S.; Haffajee, A. D.; Cugini, M. A.; Smith, C.; Kent, R. L., Jr. Microbial complexes in subgingival plaque. J. Clin. Periodontol., 1998, 25(2), 134-44.
125. Marsh, P. D. Dental plaque as a biofilm and a microbial community-implications for health and disease. BMC Oral Health, 2006, 6 Suppl 1, S14.
126. Griffen, A. L.; Beall, C. J.; Campbell, J. H.; Firestone, N. D.; Kumar, P. S.; Yang, Z. K.; Podar, M.; Leys, E. J. Distinct and complex bacterial profiles in human periodontitis and health revealed by 16S pyrosequencing. ISME J., 2012, 6(6), 1176-85.
127. Loozen, G.; Ozcelik, O.; Boon, N.; De Mol, A.; Schoen, C.; Quirynen, M.; Teughels, W. Inter-bacterial correlations in subgingival biofilms: a large-scale survey. J. Clin. Periodontol., 2014, 41(1), 1-10.
128. Ji, S.; Choi, Y. Innate immune response to oral bacteria and the immune evasive characteristics of periodontal pathogens. J. Periodontal Implant Sci., 2013, 43(1), 3-11.
129. Shaddox, L.; Wiedey, J.; Bimstein, E.; Magnuson, I.; Clare-Salzler, M.; Aukhil, I.; Wallet, S. M. Hyper-responsive phenotype in localized aggressive periodontitis. J. Dent. Res., 2010, 89(2), 143-8.
130. Feng, Z.; Weinberg, A. Role of bacteria in health and disease of periodontal tissues. Periodontol. 2000, 2006, 40, 50-76.
131. Liang, S.; Krauss, J. L.; Domon, H.; McIntosh, M. L.; Hosur, K. B.; Qu, H.; Li, F.; Tzekou, A.; Lambris, J. D.; Hajishengallis, G. The C5a receptor impairs IL-12-dependent clearance of Porphyromonas gingivalis and is required for induction of periodontal bone loss. J. Immunol., 2011, 186(2), 869-77.
132. Hajishengallis, G.; Wang, M.; Liang, S.; Triantafilou, M.; Triantafilou, K. Pathogen induction of CXCR4/TLR2 cross-talk impairs host defense function. Proc. Natl. Acad. Sci. U. S. A., 2008, 105(36), 13532-7.
133. Hajishengallis, G.; Shakhatreh, M. A.; Wang, M.; Liang, S. Complement receptor 3 blockade promotes IL-12-mediated clearance of Porphyromonas gingivalis and negates its virulence in vivo. J. Immunol., 2007, 179(4), 2359-67.
134. Mancl, K. A.; Kirsner, R. S.; Ajdic, D. Wound biofilms: lessons learned from oral biofilms. Wound Repair Regen., 2013, 21(3), 352-62.
135. Ohlrich, E. J.; Cullinan, M. P.; Seymour, G. J. The immunopathogenesis of periodontal disease. Aust. Dent. J., 2009, 54 Suppl 1, S2-10.
136. Jensen, P. O.; Givskov, M.; Bjarnsholt, T.; Moser, C. The immune system vs. Pseudomonas aeruginosa biofilms. FEMS Immunol. Med. Microbiol., 2010, 59(3), 292-305.
137. Loe, H.; Theilade, E.; Jensen, S. B. Experimental Gingivitis in Man. J. Periodontol., 1965, 36, 177-87.
138. Nyvad, B.; Kilian, M. Comparison of the initial streptococcal microflora on dental enamel in caries-active and in caries-inactive individuals. Caries Res., 1990, 24(4), 267-72.
139. Jenkinson, H. F. Beyond the oral microbiome. Environ. Microbiol., 2011, 13(12), 3077-87.
140. Nobbs, A. H.; Lamont, R. J.; Jenkinson, H. F. Streptococcus adherence and colonization. Microbiol. Mol. Biol. Rev., 2009, 73(3), 407-50.
141. Aas, J. A.; Paster, B. J.; Stokes, L. N.; Olsen, I.; Dewhirst, F. E. Defining the normal bacterial flora of the oral cavity. J. Clin. Microbiol., 2005, 43(11), 5721-32.
142. Whitmore, S. E.; Lamont, R. J. The pathogenic persona of community-associated oral streptococci. Mol. Microbiol., 2011, 81(2), 305-14.
143. Kuboniwa, M.; Lamont, R. J. Subgingival biofilm formation. Periodontol. 2000, 2010, 52(1), 38-52.
144. Socransky, S. S.; Haffajee, A. D. Periodontal microbial ecology. Periodontol. 2000, 2005, 38, 135-87.
145. Li, J.; Helmerhorst, E. J.; Leone, C. W.; Troxler, R. F.; Yaskell, T.; Haffajee, A. D.; Socransky, S. S.; Oppenheim, F. G. Identification of early microbial colonizers in human dental biofilm. J. Appl. Microbiol., 2004, 97(6), 1311-8.
146. Lang, N. P.; Cumming, B. R.; Loe, H. Toothbrushing frequency as it relates to plaque development and gingival health. J. Periodontol., 1973, 44(7), 396-405.
147. Pihlstrom, B. L.; Michalowicz, B. S.; Johnson, N. W. Periodontal diseases. Lancet, 2005, 366(9499), 1809-20.
148. Wright, C. J.; Burns, L. H.; Jack, A. A.; Back, C. R.; Dutton, L. C.; Nobbs, A. H.; Lamont, R. J.; Jenkinson, H. F.; Microbial interactions in building of communities. Mol. Oral Microbiol., 2013, 28(2), 83-101.
149. Rickard, A. H.; Campagna, S. R.; Kolenbrander, P. E. Autoinducer-2 is produced in saliva-fed flow conditions relevant to natural oral biofilms. J. Appl. Microbiol., 2008, 105(6), 2096-103.
150. McNab, R.; Ford, S. K.; El-Sabaeny, A.; Barbieri, B.; Cook, G. S.; Lamont, R. J. LuxS-based signaling in Streptococcus gordonii: autoinducer 2 controls carbohydrate metabolism and biofilm formation with Porphyromonas gingivalis. J. Bacteriol., 2003, 185(1), 274-84.
151. Bamford, C. V.; d'Mello, A.; Nobbs, A. H.; Dutton, L. C.; Vickerman, M. M.; Jenkinson, H. F. Streptococcus gordonii modulates Candida albicans biofilm formation through intergeneric communication. Infect. Immun., 2009, 77(9), 3696-704.
152. Scannapieco, F. A.; Bush, R. B.; Paju, S. Associations between periodontal disease and risk for nosocomial bacterial pneumonia and chronic obstructive pulmonary disease. A systematic review. Ann. Periodontol., 2003, 8(1), 54-69.
153. Scannapieco, F. A.; Papandonatos, G. D.; Dunford, R. G. Associations between oral conditions and respiratory disease in a national sample survey population. Ann. Periodontol., 1998, 3(1), 251-6.
154. Azarpazhooh, A.; Leake, J. L. Systematic review of the association between respiratory diseases and oral health. J. Periodontol., 2006, 77(9), 1465-82.
155. Cullinan, M. P.; Seymour, G. J. Periodontal disease and systemic illness: will the evidence ever be enough? Periodontol. 2000, 2013, 62(1), 271-86.
156. Bahekar, A. A.; Singh, S.; Saha, S.; Molnar, J.; Arora, R. The prevalence and incidence of coronary heart disease is significantly increased in periodontitis: a meta-analysis. Am. Heart J., 2007, 154(5), 830-7.
157. Humphrey, L. L.; Fu, R.; Buckley, D. I.; Freeman, M.; Helfand, M. Periodontal disease and coronary heart disease incidence: a systematic review and meta-analysis. J. Gen. Intern. Med., 2008, 23(12), 2079-86.
158. Lockhart, P. B.; Bolger, A. F.; Papapanou, P. N.; Osinbowale, O.; Trevisan, M.; Levison, M. E.; Taubert, K. A.; Newburger, J. W.; Gornik, H. L.; Gewitz, M. H.; Wilson, W. R.; Smith, S. C., Jr.; Baddour, L. M.; American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young, Council on Epidemiology and Prevention, Council on Peripheral Vascular Disease, and Council on Clinical Cardiology. Periodontal disease and atherosclerotic vascular disease: does the evidence support an independent association?: a scientific statement from the American Heart Association. Circulation, 2012, 125(20), 2520-44.
159. Hirschfeld, J.; Kawai, T. Oral inflammation and bacteremia: implications for chronic and acute systemic diseases involving major organs. Cardiovasc. Hematol. Disord. Drug Targets, 2015, 15(1), 70-84.
160. Saremi, A.; Nelson, R. G.; Tulloch-Reid, M.; Hanson, R. L.; Sievers, M. L.; Taylor, G. W.; Shlossman, M.; Bennett, P. H.; Genco, R.; Knowler, W. C. Periodontal disease and mortality in type 2 diabetes. Diabetes Care, 2005, 28(1), 27-32.
161. Taylor, G. W.; Borgnakke, W. S. Periodontal disease: associations with diabetes, glycemic control and complications. Oral Dis., 2008, 14(3), 191-203.
162. Chambrone, L.; Guglielmetti, M. R.; Pannuti, C. M.; Chambrone, L. A. Evidence grade associating periodontitis to preterm birth and/or low birth weight: I. A systematic review of prospective cohort studies. J. Clin. Periodontol., 2011, 38(9), 795-808.
163. George, A.; Shamim, S.; Johnson, M.; Ajwani, S.; Bhole, S.; Blinkhorn, A.; Ellis, S.; Andrews, K. Periodontal treatment during pregnancy and birth outcomes: a meta-analysis of randomised trials. Int. J. Evid. Based Healthc., 2011, 9(2), 122-47.
164. McGregor, J. A.; French, J. I.; Lawellin, D.; Todd, J. K. Preterm birth and infection: pathogenic possibilities. Am. J. Reprod. Immunol. Microbiol., 1988, 16(3), 123-32.
165. Kim, A. J.; Lo, A. J.; Pullin, D. A.; Thornton-Johnson, D. S.; Karimbux, N. Y. Scaling and root planing treatment for periodontitis to reduce preterm birth and low birth weight: a systematic review and meta-analysis of randomized controlled trials. J. Periodontol., 2012, 83(12), 1508-19.
166. Kerem, B.; Rommens, J. M.; Buchanan, J. A.; Markiewicz, D.; Cox, T. K.; Chakravarti, A.; Buchwald, M.; Tsui, L. C. Identification of the cystic fibrosis gene: genetic analysis. Science, 1989, 245(4922), 1073-80.
167. Cystic Fibrosis Foundation. Patient Registry. 2012 Annual Data Report. Bethesda, Maryland: Available from: http://www. cff. org/UploadedFiles/research/ClinicalResearch/PatientRegistryReport/20 12-CFF-Patient-Registry. pdf (Accessed Feb 18, 2015).
168. Ratjen, F.; Doring, G. Cystic fibrosis. Lancet, 2003, 361(9358), 681-9.
169. Hoegger, M. J.; Fischer, A. J.; McMenimen, J. D.; Ostedgaard, L. S.; Tucker, A. J.; Awadalla, M. A.; Moninger, T. O.; Michalski, A. S.; Hoffman, E. A.; Zabner, J.; Stoltz, D. A.; Welsh, M. J. Cystic fibrosis. Impaired mucus detachment disrupts mucociliary transport in a piglet model of cystic fibrosis. Science, 2014, 345(6198), 818-22.
170. Farrell, P. M.; Li, Z.; Kosorok, M. R.; Laxova, A.; Green, C. G.; Collins, J.; Lai, H. C.; Makholm, L. M.; Rock, M. J.; Splaingard, M. L. Longitudinal evaluation of bronchopulmonary disease in children with cystic fibrosis. Pediatr. Pulmonol., 2003, 36(3), 230-40.
171. Bjarnsholt, T.; Jensen, P. O.; Fiandaca, M. J.; Pedersen, J.; Hansen, C. R.; Andersen, C. B.; Pressler, T.; Givskov, M.; Hoiby, N. Pseudomonas aeruginosa biofilms in the respiratory tract of cystic fibrosis patients. Pediatr. Pulmonol., 2009, 44(6), 547-58.
172. Lyczak, J. B.; Cannon, C. L.; Pier, G. B. Lung infections associated with cystic fibrosis. Clin. Microbiol. Rev., 2002, 15(2), 194-222.
173. Lebeaux, D.; Chauhan, A.; Rendueles, O.; Beloin, C. From in vitro to in vivo models of bacterial biofilm-related infections. Pathogens, 2013, 2(2), 288-356.
174. Rogers, G. B.; Carroll, M. P.; Serisier, D. J.; Hockey, P. M.; Kehagia, V.; Jones, G. R.; Bruce, K. D. Bacterial activity in cystic fibrosis lung infections. Respir. Res., 2005, 6, 49.
175. Harris, J. K.; De Groote, M. A.; Sagel, S. D.; Zemanick, E. T.; Kapsner, R.; Penvari, C.; Kaess, H.; Deterding, R. R.; Accurso, F. J.; Pace, N. R. Molecular identification of bacteria in bronchoalveolar lavage fluid from children with cystic fibrosis. Proc. Natl. Acad. Sci. U. S. A., 2007, 104(51), 20529-33.
176. Klepac-Ceraj, V.; Lemon, K. P.; Martin, T. R.; Allgaier, M.; Kembel, S. W.; Knapp, A. A.; Lory, S.; Brodie, E. L.; Lynch, S. V.; Bohannan, B. J.; Green, J. L.; Maurer, B. A.; Kolter, R. Relationship between cystic fibrosis respiratory tract bacterial communities and age, genotype, antibiotics and Pseudomonas aeruginosa. Environ. Microbiol., 2010, 12(5), 1293-303.
177. Ratjen, A.; Yau, Y.; Wettlaufer, J.; Matukas, L.; Zlosnik, J. E.; Speert, D. P.; LiPuma, J. J.; Tullis, E.; Waters, V. In vitro efficacy of high-dose tobramycin against Burkholderia cepacia complex and Stenotrophomonas maltophilia isolates from cystic fibrosis patients. Antimicrob. Agents Chemother., 2015, 59(1), 711-3.
178. Trancassini, M.; Iebba, V.; Citera, N.; Tuccio, V.; Magni, A.; Varesi, P.; De Biase, R. V.; Totino, V.; Santangelo, F.; Gagliardi, A.; Schippa, S. Outbreak of Achromobacter xylosoxidans in an Italian Cystic fibrosis center: genome variability, biofilm production, antibiotic resistance, and motility in isolated strains. Front. Microbiol., 2014, 5, 138.
179. Olivier, K. N.; Weber, D. J.; Wallace, R. J., Jr.; Faiz, A. R.; Lee, J. H.; Zhang, Y.; Brown-Elliot, B. A.; Handler, A.; Wilson, R. W.; Schechter, M. S.; Edwards, L. J.; Chakraborti, S.; Knowles, M. R.; Nontuberculous Mycobacteria in Cystic Fibrosis Study Group. Nontuberculous mycobacteria. I: multicenter prevalence study in cystic fibrosis. Am. J. Respir. Crit. Care Med., 2003, 167(6), 828-34.
180. Olivier, K. N.; N. T. M. in C. F. Study Group. The natural history of nontuberculous mycobacteria in patients with cystic fibrosis. Paediatr. Respir. Rev., 2004, 5 Suppl A, S213-6.
181. Conrad, D.; Haynes, M.; Salamon, P.; Rainey, P. B.; Youle, M.; Rohwer, F. Cystic fibrosis therapy: a community ecology perspective. Am. J. Respir. Cell. Mol. Biol., 2013, 48(2), 150-6.
182. Cystic Fibrosis Foundation. Patient Registry. 2010 Annual Data Report. Bethesda, Maryland: Available from: http://www. cff. org/UploadedFiles/LivingWithCF/CareCenterNetwork/PatientRegistry/2010-Patient-Registry-Report. pdf (Accessed Feb 20, 2015).
183. van der Gast, C. J.; Walker, A. W.; Stressmann, F. A.; Rogers, G. B.; Scott, P.; Daniels, T. W.; Carroll, M. P.; Parkhill, J.; Bruce, K. D. Partitioning core and satellite taxa from within cystic fibrosis lung bacterial communities. ISME J., 2011, 5(5), 780-91.
184. Rogers, G. B.; Carroll, M. P.; Serisier, D. J.; Hockey, P. M.; Jones, G.; Kehagia, V.; Connett, G. J.; Bruce, K. D. Use of 16S rRNA gene profiling by terminal restriction fragment length polymorphism analysis to compare bacterial communities in sputum and mouthwash samples from patients with cystic fibrosis. J. Clin. Microbiol., 2006, 44(7), 2601-4.
185. Rogers, G. B.; Hart, C. A.; Mason, J. R.; Hughes, M.; Walshaw, M. J.; Bruce, K. D. Bacterial diversity in cases of lung infection in cystic fibrosis patients: 16S ribosomal DNA (rDNA) length heterogeneity PCR and 16S rDNA terminal restriction fragment length polymorphism profiling. J. Clin. Microbiol., 2003, 41(8), 3548-58.
186. Goddard, A. F.; Staudinger, B. J.; Dowd, S. E.; Joshi-Datar, A.; Wolcott, R. D.; Aitken, M. L.; Fligner, C. L.; Singh, P. K. Direct sampling of cystic fibrosis lungs indicates that DNA-based analyses of upper-airway specimens can misrepresent lung microbiota. Proc. Natl. Acad. Sci. U. S. A., 2012, 109(34), 13769-74.
187. Li, Z.; Kosorok, M. R.; Farrell, P. M.; Laxova, A.; West, S. E.; Green, C. G.; Collins, J.; Rock, M. J.; Splaingard, M. L. Longitudinal development of mucoid Pseudomonas aeruginosa infection and lung disease progression in children with cystic fibrosis. JAMA, 2005, 293(5), 581-8.
188. Pressler, T.; Frederiksen, B.; Skov, M.; Garred, P.; Koch, C.; Hoiby, N. Early rise of anti-Pseudomonas antibodies and a mucoid phenotype of Pseudomonas aeruginosa are risk factors for development of chronic lung infection-a case control study. J. Cyst. Fibros., 2006, 5(1), 9-15.
189. Hoffmann, N.; Rasmussen, T. B.; Jensen, P. O.; Stub, C.; Hentzer, M.; Molin, S.; Ciofu, O.; Givskov, M.; Johansen, H. K.; Hoiby, N.; Novel mouse model of chronic Pseudomonas aeruginosa lung infection mimicking cystic fibrosis. Infect. Immun., 2005, 73(4), 2504-14.
190. Jelsbak, L.; Johansen, H. K.; Frost, A. L.; Thogersen, R.; Thomsen, L. E.; Ciofu, O.; Yang, L.; Haagensen, J. A.; Hoiby, N.; Molin, S. Molecular epidemiology and dynamics of Pseudomonas aeruginosa populations in lungs of cystic fibrosis patients. Infect. Immun., 2007, 75(5), 2214-24.
191. Koch, C.; Hoiby, N. Pathogenesis of cystic fibrosis. Lancet, 1993, 341(8852), 1065-9.
192. Hentzer, M.; Teitzel, G. M.; Balzer, G. J.; Heydorn, A.; Molin, S.; Givskov, M.; Parsek, M. R. Alginate overproduction affects Pseudomonas aeruginosa biofilm structure and function. J. Bacteriol., 2001, 183(18), 5395-401.
193. Barken, K. B.; Pamp, S. J.; Yang, L.; Gjermansen, M.; Bertrand, J. J.; Klausen, M.; Givskov, M.; Whitchurch, C. B.; Engel, J. N.; Tolker-Nielsen, T. Roles of type IV pili, flagellum-mediated motility and extracellular DNA in the formation of mature multicellular structures in Pseudomonas aeruginosa biofilms. Environ. Microbiol., 2008, 10(9), 2331-43.
194. Yang, L.; Nilsson, M.; Gjermansen, M.; Givskov, M.; Tolker-Nielsen, T. Pyoverdine and PQS mediated subpopulation interactions involved in Pseudomonas aeruginosa biofilm formation. Mol. Microbiol., 2009, 74(6), 1380-92.
195. Singh, P. K. Iron sequestration by human lactoferrin stimulates Pseudomonas aeruginosa surface motility and blocks biofilm formation. Biometals, 2004, 17(3), 267-70.
196. Patriquin, G. M.; Banin, E.; Gilmour, C.; Tuchman, R.; Greenberg, E. P.; Poole, K. Influence of quorum sensing and iron on twitching motility and biofilm formation in Pseudomonas aeruginosa. J. Bacteriol., 2008, 190(2), 662-71.
197. Yang, L.; Jelsbak, L.; Marvig, R. L.; Damkiaer, S.; Workman, C. T.; Rau, M. H.; Hansen, S. K.; Folkesson, A.; Johansen, H. K.; Ciofu, O.; Hoiby, N.; Sommer, M. O.; Molin, S. Evolutionary dynamics of bacteria in a human host environment. Proc. Natl. Acad. Sci. U. S. A., 2011, 108(18), 7481-6.
198. De Kievit, T. R.; Gillis, R.; Marx, S.; Brown, C.; Iglewski, B. H. Quorum-sensing genes in Pseudomonas aeruginosa biofilms: their role and expression patterns. Appl. Environ. Microbiol., 2001, 67(4), 1865-73.
199. Lequette, Y.; Greenberg, E. P. Timing and localization of rhamnolipid synthesis gene expression in Pseudomonas aeruginosa biofilms. J. Bacteriol., 2005, 187(1), 37-44.
200. Kaneko, Y.; Thoendel, M.; Olakanmi, O.; Britigan, B. E.; Singh, P. K. The transition metal gallium disrupts Pseudomonas aeruginosa iron metabolism and has antimicrobial and antibiofilm activity. J. Clin. Invest., 2007, 117(4), 877-88.
201. Reis, R. S.; Pereira, A. G.; Neves, B. C.; Freire, D. M. Gene regulation of rhamnolipid production in Pseudomonas aeruginosa-a review. Bioresour. Technol., 2011, 102(11), 6377-84.
202. Abdel-Mawgoud, A. M.; Lepine, F.; Deziel, E. Rhamnolipids: diversity of structures, microbial origins and roles. Appl. Microbiol. Biotechnol., 2010, 86(5), 1323-36.
203. Pamp, S. J.; Tolker-Nielsen, T. Multiple roles of biosurfactants in structural biofilm development by Pseudomonas aeruginosa. J. Bacteriol., 2007, 189(6), 2531-9.
204. Boles, B. R.; Thoendel, M.; Singh, P. K. Rhamnolipids mediate detachment of Pseudomonas aeruginosa from biofilms. Mol. Microbiol., 2005, 57(5), 1210-23.
205. Kolpen, M.; Hansen, C. R.; Bjarnsholt, T.; Moser, C.; Christensen, L. D.; van Gennip, M.; Ciofu, O.; Mandsberg, L.; Kharazmi, A.; Doring, G.; Givskov, M.; Hoiby, N.; Jensen, P. O. Polymorphonuclear leucocytes consume oxygen in sputum from chronic Pseudomonas aeruginosa pneumonia in cystic fibrosis. Thorax, 2010, 65(1), 57-62.
206. Hull, J.; Vervaart, P.; Grimwood, K.; Phelan, P. Pulmonary oxidative stress response in young children with cystic fibrosis. Thorax, 1997, 52(6), 557-60.
207. Bruce, M. C.; Poncz, L.; Klinger, J. D.; Stern, R. C.; Tomashefski, J. F., Jr.; Dearborn, D. G. Biochemical and pathologic evidence for proteolytic destruction of lung connective tissue in cystic fibrosis. Am. Rev. Respir. Dis., 1985, 132(3), 529-35.
208. Pedersen, S. S.; Hoiby, N.; Espersen, F.; Koch, C. Role of alginate in infection with mucoid Pseudomonas aeruginosa in cystic fibrosis. Thorax, 1992, 47(1), 6-13.
209. Hoiby, N. Pseudomonas aeruginosa infection in cystic fibrosis. Diagnostic and prognostic significance of Pseudomonas aeruginosa precipitins determined by means of crossed immunoelectrophoresis. A survey. Acta. Pathol. Microbiol. Scand. Suppl., 1977, (262), 1-96.
210. Kronborg, G.; Shand, G. H.; Fomsgaard, A.; Hoiby, N. Lipopolysaccharide is present in immune complexes isolated from sputum in patients with cystic fibrosis and chronic Pseudomonas aeruginosa lung infection. APMIS, 1992, 100(2), 175-80.
211. Pier, G. B.; Coleman, F.; Grout, M.; Franklin, M.; Ohman, D. E. Role of alginate O acetylation in resistance of mucoid Pseudomonas aeruginosa to opsonic phagocytosis. Infect. Immun., 2001, 69(3), 1895-901.
212. Jensen, P. O.; Bjarnsholt, T.; Phipps, R.; Rasmussen, T. B.; Calum, H.; Christoffersen, L.; Moser, C.; Williams, P.; Pressler, T.; Givskov, M.; Hoiby, N. Rapid necrotic killing of polymorphonuclear leukocytes is caused by quorum-sensing-controlled production of rhamnolipid by Pseudomonas aeruginosa. Microbiology, 2007, 153(Pt 5), 1329-38.
213. Alhede, M.; Bjarnsholt, T.; Jensen, P. O.; Phipps, R. K.; Moser, C.; Christophersen, L.; Christensen, L. D.; van Gennip, M.; Parsek, M.; Hoiby, N.; Rasmussen, T. B.; Givskov, M. Pseudomonas aeruginosa recognizes and responds aggressively to the presence of polymorphonuclear leukocytes. Microbiology, 2009, 155(Pt 11), 3500-8.
214. Darch, S. E.; McNally, A.; Harrison, F.; Corander, J.; Barr, H. L.; Paszkiewicz, K.; Holden, S.; Fogarty, A.; Crusz, S. A.; Diggle, S. P. Recombination is a key driver of genomic and phenotypic diversity in a Pseudomonas aeruginosa population during cystic fibrosis infection. Sci. Rep., 2015, 5, 7649.
215. Cox, M. J.; Allgaier, M.; Taylor, B.; Baek, M. S.; Huang, Y. J.; Daly, R. A.; Karaoz, U.; Andersen, G. L.; Brown, R.; Fujimura, K. E.; Wu, B.; Tran, D.; Koff, J.; Kleinhenz, M. E.; Nielson, D.; Brodie, E. L.; Lynch, S. V. Airway microbiota and pathogen abundance in age-stratified cystic fibrosis patients. PLoS One, 2010, 5(6), e11044.
216. Bowman, C. M. The long-term use of inhaled tobramycin in patients with cystic fibrosis. J. Cyst. Fibros., 2002, 1(Suppl 2), 194-8.
217. Lynch, S. V.; Bruce, K. D. The cystic fibrosis airway microbiome. Cold Spring Harb. Perspect. Med., 2013, 3(3), a009738.
218. Zhao, J.; Schloss, P. D.; Kalikin, L. M.; Carmody, L. A.; Foster, B. K.; Petrosino, J. F.; Cavalcoli, J. D.; VanDevanter, D. R.; Murray, S.; Li, J. Z.; Young, V. B.; LiPuma, J. J. Decade-long bacterial community dynamics in cystic fibrosis airways. Proc. Natl. Acad. Sci. U. S. A., 2012, 109(15), 5809-14.
219. Bjarnsholt, T.; Ciofu, O.; Molin, S.; Givskov, M.; Hoiby, N. Applying insights from biofilm biology to drug development-can a new approach be developed? Nat. Rev. Drug. Discov., 2013, 12(10), 791-808.
220. Walters, M. C., 3rd; Roe, F.; Bugnicourt, A.; Franklin, M. J.; Stewart, P. S. Contributions of antibiotic penetration, oxygen limitation, and low metabolic activity to tolerance of Pseudomonas aeruginosa biofilms to ciprofloxacin and tobramycin. Antimicrob. Agents Chemother., 2003, 47(1), 317-23.
221. Stewart, P. S. Theoretical aspects of antibiotic diffusion into microbial biofilms. Antimicrob. Agents Chemother., 1996, 40(11), 2517-22.
222. Tseng, B. S.; Zhang, W.; Harrison, J. J.; Quach, T. P.; Song, J. L.; Penterman, J.; Singh, P. K.; Chopp, D. L.; Packman, A. I.; Parsek, M. R. The extracellular matrix protects Pseudomonas aeruginosa biofilms by limiting the penetration of tobramycin. Environ. Microbiol., 2013, 15(10), 2865-78.
223. Alipour, M.; Suntres, Z. E.; Omri, A.; Importance of DNase and alginate lyase for enhancing free and liposome encapsulated aminoglycoside activity against Pseudomonas aeruginosa. J. Antimicrob. Chemother., 2009, 64(2), 317-25.
224. Williamson, K. S.; Richards, L. A.; Perez-Osorio, A. C.; Pitts, B.; McInnerney, K.; Stewart, P. S.; Franklin, M. J. Heterogeneity in Pseudomonas aeruginosa biofilms includes expression of ribosome hibernation factors in the antibiotic-tolerant subpopulation and hy poxia-induced stress response in the metabolically active population. J. Bacteriol., 2012, 194(8), 2062-73.
225. Chiang, W. C.; Pamp, S. J.; Nilsson, M.; Givskov, M.; Tolker-Nielsen, T. The metabolically active subpopulation in Pseudomonas aeruginosa biofilms survives exposure to membranetargeting antimicrobials via distinct molecular mechanisms. FEMS Immunol. Med. Microbiol., 2012, 65(2), 245-56.
226. De Groote, V. N.; Verstraeten, N.; Fauvart, M.; Kint, C. I.; Verbeeck, A. M.; Beullens, S.; Cornelis, P.; Michiels, J. Novel persistence genes in Pseudomonas aeruginosa identified by highthroughput screening. FEMS Microbiol. Lett., 2009, 297(1), 73-9.
227. Lewis, K. Persister cells. Annu. Rev. Microbiol., 2010, 64, 357-72.
228. Vazquez-Laslop, N.; Lee, H.; Neyfakh, A. A. Increased persistence in Escherichia coli caused by controlled expression of toxins or other unrelated proteins. J. Bacteriol., 2006, 188(10), 3494-7.
229. Brooun, A.; Liu, S.; Lewis, K. A dose-response study of antibiotic resistance in Pseudomonas aeruginosa biofilms. Antimicrob. Agents Chemother., 2000, 44(3), 640-6.
230. Lewis, K. Riddle of biofilm resistance. Antimicrob. Agents Chemother., 2001, 45(4), 999-1007.
231. Balaban, N. Q.; Merrin, J.; Chait, R.; Kowalik, L.; Leibler, S. Bacterial persistence as a phenotypic switch. Science, 2004, 305(5690), 1622-5.
232. Dibdin, G. H.; Assinder, S. J.; Nichols, W. W.; Lambert, P. A. Mathematical model of beta-lactam penetration into a biofilm of Pseudomonas aeruginosa while undergoing simultaneous inactivation by released beta-lactamases. J. Antimicrob. Chemother., 1996, 38(5), 757-69.
233. Ciofu, O.; Beveridge, T. J.; Kadurugamuwa, J.; Walther-Rasmussen, J.; Hoiby, N. Chromosomal beta-lactamase is packaged into membrane vesicles and secreted from Pseudomonas aeruginosa. J. Antimicrob. Chemother., 2000, 45(1), 9-13.
234. Giwercman, B.; Meyer, C.; Lambert, P. A.; Reinert, C.; Hoiby, N. High-level beta-lactamase activity in sputum samples from cystic fibrosis patients during antipseudomonal treatment. Antimicrob. Agents Chemother., 1992, 36(1), 71-6.
235. Hill, D.; Rose, B.; Pajkos, A.; Robinson, M.; Bye, P.; Bell, S.; Elkins, M.; Thompson, B.; Macleod, C.; Aaron, S. D.; Harbour, C. Antibiotic susceptabilities of Pseudomonas aeruginosa isolates derived from patients with cystic fibrosis under aerobic, anaerobic, and biofilm conditions. J. Clin. Microbiol., 2005, 43(10), 5085-90.
236. Johansen, H. K.; Moskowitz, S. M.; Ciofu, O.; Pressler, T.; Hoiby, N. Spread of colistin resistant non-mucoid Pseudomonas aeruginosa among chronically infected Danish cystic fibrosis patients. J. Cyst. Fibros., 2008, 7(5), 391-7.
237. Haagensen, J. A.; Klausen, M.; Ernst, R. K.; Miller, S. I.; Folkesson, A.; Tolker-Nielsen, T.; Molin, S. Differentiation and distribution of colistin-and sodium dodecyl sulfate-tolerant cells in Pseudomonas aeruginosa biofilms. J. Bacteriol., 2007, 189(1), 28-37.
238. Pamp, S. J.; Gjermansen, M.; Johansen, H. K.; Tolker-Nielsen, T. Tolerance to the antimicrobial peptide colistin in Pseudomonas aeruginosa biofilms is linked to metabolically active cells, and depends on the pmr and mexAB-oprM genes. Mol. Microbiol., 2008, 68(1), 223-40.
239. Zhang, L.; Mah, T. F. Involvement of a novel efflux system in biofilm-specific resistance to antibiotics. J. Bacteriol., 2008, 190(13), 4447-52.
240. Gillis, R. J.; White, K. G.; Choi, K. H.; Wagner, V. E.; Schweizer, H. P.; Iglewski, B. H. Molecular basis of azithromycin-resistant Pseudomonas aeruginosa biofilms. Antimicrob. Agents Chemother., 2005, 49(9), 3858-67.
241. Liao, J.; Schurr, M. J.; Sauer, K. The MerR-like regulator BrlR confers biofilm tolerance by activating multidrug efflux pumps in Pseudomonas aeruginosa biofilms. J. Bacteriol., 2013, 195(15), 3352-63.
242. Drenkard, E.; Ausubel, F. M. Pseudomonas biofilm formation and antibiotic resistance are linked to phenotypic variation. Nature, 2002, 416(6882), 740-3.
243. Mikkelsen, H.; Sivaneson, M.; Filloux, A. Key two-component regulatory systems that control biofilm formation in Pseudomonas aeruginosa. Environ. Microbiol., 2011, 13(7), 1666-81.
244. Molin, S.; Tolker-Nielsen, T. Gene transfer occurs with enhanced efficiency in biofilms and induces enhanced stabilisation of the biofilm structure. Curr. Opin. Biotechnol., 2003, 14(3), 255-61.
245. Mai-Prochnow, A.; Lucas-Elio, P.; Egan, S.; Thomas, T.; Webb, J. S.; Sanchez-Amat, A.; Kjelleberg, S. Hydrogen peroxide linked to lysine oxidase activity facilitates biofilm differentiation and dispersal in several gram-negative bacteria. J. Bacteriol., 2008, 190(15), 5493-501.
246. Hassett, D. J.; Ma, J. F.; Elkins, J. G.; McDermott, T. R.; Ochsner, U. A.; West, S. E.; Huang, C. T.; Fredericks, J.; Burnett, S.; Stewart, P. S.; McFeters, G.; Passador, L.; Iglewski, B. H. Quorum sensing in Pseudomonas aeruginosa controls expression of catalase and superoxide dismutase genes and mediates biofilm susceptibility to hydrogen peroxide. Mol. Microbiol., 1999, 34(5), 1082-93.
247. Ciofu, O.; Riis, B.; Pressler, T.; Poulsen, H. E.; Hoiby, N. Occurrence of hypermutable Pseudomonas aeruginosa in cystic fibrosis patients is associated with the oxidative stress caused by chronic lung inflammation. Antimicrob. Agents Chemother., 2005, 49(6), 2276-82.
248. Conibear, T. C.; Collins, S. L.; Webb, J. S. Role of mutation in Pseudomonas aeruginosa biofilm development. PLoS One, 2009, 4(7), e6289.
249. Boles, B. R.; Singh, P. K. Endogenous oxidative stress produces diversity and adaptability in biofilm communities. Proc. Natl. Acad. Sci. U. S. A., 2008, 105(34), 12503-8.
250. Frederiksen, B.; Lanng, S.; Koch, C.; Hoiby, N. Improved survival in the Danish center-treated cystic fibrosis patients: results of aggressive treatment. Pediatr. Pulmonol., 1996, 21(3), 153-8.
251. Doring, G.; Hoiby, N.; Consensus Study, G. Early intervention and prevention of lung disease in cystic fibrosis: a European consensus. J. Cyst. Fibros., 2004, 3(2), 67-91.
252. Hoiby, N.; Pedersen, S. S. Estimated risk of cross-infection with Pseudomonas aeruginosa in Danish cystic fibrosis patients. Acta Paediatr Scand, 1989, 78(3), 395-404.
253. Sen, C. K.; Gordillo, G. M.; Roy, S.; Kirsner, R.; Lambert, L.; Hunt, T. K.; Gottrup, F.; Gurtner, G. C.; Longaker, M. T. Human skin wounds: a major and snowballing threat to public health and the economy. Wound Repair Regen., 2009, 17(6), 763-71.
254. Brem, H.; Stojadinovic, O.; Diegelmann, R. F.; Entero, H.; Lee, B.; Pastar, I.; Golinko, M.; Rosenberg, H.; Tomic-Canic, M. Molecular markers in patients with chronic wounds to guide surgical debridement. Mol. Med., 2007, 13(1-2), 30-9.
255. Tomic-Canic, M.; Ayello, E. A.; Stojadinovic, O.; Golinko, M. S.; Brem, H. Using gene transcription patterns (bar coding scans) to guide wound debridement and healing. Adv. Skin. Wound Care, 2008, 21(10), 487-92; quiz 493-4.
256. Upton, D.; Hender, C.; Solowiej, K. Mood disorders in patients with acute and chronic wounds: a health professional perspective. J. Wound Care, 2012, 21(1), 42-8.
257. Posnett, J.; Franks, P. J. The burden of chronic wounds in the UK. Nurs. Times, 2008, 104(3), 44-5.
258. Mihai, M. M.; Holban, A. M.; Giurcaneanu, C.; Popa, L. G.; Buzea, M.; Filipov, M.; Lazar, V.; Chifiriuc, M. C.; Popa, M. I. Identification and phenotypic characterization of the most frequent bacterial etiologies in chronic skin ulcers. Rom. J. Morphol. Embryol., 2014, 55(4), 1401-8.
259. Green, J.; Jester, R.; McKinley, R.; Pooler, A. The impact of chronic venous leg ulcers: a systematic review. J. Wound Care, 2014, 23(12), 601-12.
260. Alexander, S. J. Time to get serious about assessing-and managing-psychosocial issues associated with chronic wounds. Curr. Opin. Support Palliat. Care, 2013, 7(1), 95-100.
261. Cole-King, A.; Harding, K. G. Psychological factors and delayed healing in chronic wounds. Psychosom. Med., 2001, 63(2), 216-20.
262. Jones, J.; Barr, W.; Robinson, J.; Carlisle, C. Depression in patients with chronic venous ulceration. Br. J. Nurs., 2006, 15(11), S17-23.
263. Upton, D.; Andrews, A. Pain and trauma in negative pressure wound therapy: a review. Int. Wound J., 2015, 12(1), 100-5.
264. Upton, D.; Penn, F.; Richardson, C.; Rippon, M. Psychological management of wound pruritus. J. Wound Care, 2014, 23(6), 291-2, 294, 296-9.
265. Hamer, C.; Cullum, N. A.; Roe, B. H. Patients' perceptions of chronic leg ulcers. J Wound Care, 1994, 3(2): 99-101.
266. Jones, J. E.; Robinson, J.; Barr, W.; Carlisle, C. Impact of exudate and odour from chronic venous leg ulceration. Nurs. Stand., 2008, 22(45), 53-4, 56, 58 passim.
267. Guo, S.; Dipietro, L. A. Factors affecting wound healing. J. Dent. Res., 2010, 89(3), 219-29.
268. Wales, S. A world of pain. Nurs. Stand., 2006, 20(36), 24-5.
269. Coutts, P.; Woo, K. Y.; Bourque, S. Treating patients with painful chronic wounds. Nurs. Stand., 2008, 23(10), 42-6.
270. Upton, D.; Andrews, A. Sleep disruption in patients with chronic leg ulcers. J. Wound Care, 2013, 22(8), 389-90, 392, 394.
271. Scales, B. S.; Huffnagle, G. B. The microbiome in wound repair and tissue fibrosis. J. Pathol., 2013, 229(2), 323-31.
272. Yager, D. R.; Nwomeh, B. C. The proteolytic environment of chronic wounds. Wound Repair Regen., 1999, 7(6), 433-41.
273. Diegelmann, R. F. Excessive neutrophils characterize chronic pressure ulcers. Wound Repair Regen., 2003, 11(6), 490-5.
274. James, G. A.; Swogger, E.; Wolcott, R.; Pulcini, E.; Secor, P.; Sestrich, J.; Costerton, J. W.; Stewart, P. S. Biofilms in chronic wounds. Wound Repair Regen., 2008, 16(1), 37-44.
275. Percival, S. L.; McCarty, S.; Hunt, J. A.; Woods, E. J. The effects of pH on wound healing, biofilms, and antimicrobial efficacy. Wound Repair Regen., 2014, 22(2), 174-86.
276. Georgescu, M.; Marutescu, L.; Trifu, V.; Marinescu, V.; Toropoc, I.; Chirita, D. A.; Poenaru, M.; Darmanescu, M. S.; Costache, D.; Chifiriuc, M. C. The profile of chronic skin wound microbiota in hospitalized dermatology patients. Biointerface Res. Appl. Chem., 2014, 4(6): 885890.
277. Jockenhofer, F.; Chapot, V.; Stoffels-Weindorf, M.; Korber, A.; Klode, J.; Buer, J.; Kupper, B.; Roesch, A.; Dissemond, J. Bacterial spectrum colonizing chronic leg ulcers: a 10-year comparison from a German wound care center. J. Dtsch. Dermatol. Ges., 2014, 12(12), 1121-7.
278. Korber, A.; Schmid, E. N.; Buer, J.; Klode, J.; Schadendorf, D.; Dissemond, J. Bacterial colonization of chronic leg ulcers: current results compared with data 5 years ago in a specialized dermatology department. J. Eur. Acad. Dermatol. Venereol., 2010, 24(9), 1017-25.
279. Moremi, N.; Mushi, M. F.; Fidelis, M.; Chalya, P.; Mirambo, M.; Mshana, S. E. Predominance of multi-resistant gram-negative bacteria colonizing chronic lower limb ulcers (CLLUs) at Bugando Medical Center. BMC Res. Notes, 2014, 7, 211.
280. Price, L. B.; Liu, C. M.; Frankel, Y. M.; Melendez, J. H.; Aziz, M.; Buchhagen, J.; Contente-Cuomo, T.; Engelthaler, D. M.; Keim, P. S.; Ravel, J.; Lazarus, G. S.; Zenilman, J. M. Macroscale spatial variation in chronic wound microbiota: a cross-sectional study. Wound Repair Regen., 2011, 19(1), 80-8.
281. Grice, E. A.; Snitkin, E. S.; Yockey, L. J.; Bermudez, D. M.; Program, N. C. S.; Liechty, K. W.; Segre, J. A. Longitudinal shift in diabetic wound microbiota correlates with prolonged skin defense response. Proc. Natl. Acad. Sci. U. S. A., 2010, 107(33), 14799-804.
282. Gardner, S. E.; Frantz, R. A. Wound bioburden and infectionrelated complications in diabetic foot ulcers. Biol. Res. Nurs., 2008, 10(1), 44-53.
283. Bowler, P. G.; Duerden, B. I.; Armstrong, D. G. Wound microbiology and associated approaches to wound management. Clin. Microbiol. Rev., 2001, 14(2), 244-69.
284. Rhoads, D. D.; Cox, S. B.; Rees, E. J.; Sun, Y.; Wolcott, R. D. Clinical identification of bacteria in human chronic wound infections: culturing vs. 16S ribosomal DNA sequencing. BMC Infect. Dis., 2012, 12, 321.
285. Frank, D. N.; Wysocki, A.; Specht-Glick, D. D.; Rooney, A.; Feldman, R. A.; St Amand, A. L.; Pace, N. R.; Trent, J. D. Microbial diversity in chronic open wounds. Wound Repair Regen., 2009, 17(2), 163-72.
286. Han, A.; Zenilman, J. M.; Melendez, J. H.; Shirtliff, M. E.; Agostinho, A.; James, G.; Stewart, P. S.; Mongodin, E. F.; Rao, D.; Rickard, A. H.; Lazarus, G. S. The importance of a multifaceted approach to characterizing the microbial flora of chronic wounds. Wound Repair Regen., 2011, 19(5), 532-41.
287. Oliver, J. D. Recent findings on the viable but nonculturable state in pathogenic bacteria. FEMS Microbiol. Rev., 2010, 34(4), 415-25.
288. Holban, A. M.; Chifiriuc, M. C.; Cotar, A. I,; Bleotu, C.; Grumezescu, A. M.; Banu, O.; Lazar, V. Virulence markers in Pseudomonas aeruginosa isolates from hospital-acquired infections occurred in patients with underlying cardiovascular disease. Rom. Biotech. Lett., 2013, 18(6): 8843-8854.
289. Kolar, S. L.; Ibarra, J. A.; Rivera, F. E.; Mootz, J. M.; Davenport, J. E.; Stevens, S. M.; Horswill, A. R.; Shaw, L. N. Extracellular proteases are key mediators of Staphylococcus aureus virulence via the global modulation of virulence-determinant stability. Microbiologyopen, 2013, 2(1), 18-34.
290. Birkenhauer, E.; Neethirajan, S.; Weese, J. S. Collagen and hyaluronan at wound sites influence early polymicrobial biofilm adhesive events. BMC Microbiol., 2014, 14, 191.
291. Harrison, F.; Browning, L. E.; Vos, M.; Buckling, A. Cooperation and virulence in acute Pseudomonas aeruginosa infections. BMC Biol., 2006, 4, 21.
292. Harrison, F.; Paul, J.; Massey, R. C.; Buckling, A. Interspecific competition and siderophore-mediated cooperation in Pseudomonas aeruginosa. ISME J., 2008, 2(1), 49-55.
293. Mashburn, L. M.; Jett, A. M.; Akins, D. R.; Whiteley, M. Staphylococcus aureus serves as an iron source for Pseudomonas aeruginosa during in vivo coculture. J. Bacteriol., 2005, 187(2), 554-66.
294. Vandecandelaere, I.; Depuydt, P.; Nelis, H. J.; Coenye, T. Protease production by Staphylococcus epidermidis and its effect on Staphylococcus aureus biofilms. Pathog. Dis., 2014, 70(3), 321-31.
295. Leung, K. P.; D'Arpa, P.; Seth, A. K.; Geringer, M. R.; Jett, M.; Xu, W.; Hong, S. J.; Galiano, R. D.; Chen, T.; Mustoe, T. A. Dermal wound transcriptomic responses to infection with Pseudomonas aeruginosa versus Klebsiella pneumoniae in a rabbit ear wound model. BMC Clin. Pathol., 2014, 14, 20.
296. Fazli, M.; Bjarnsholt, T.; Kirketerp-Moller, K.; Jorgensen, A.; Andersen, C. B.; Givskov, M.; Tolker-Nielsen, T. Quantitative analysis of the cellular inflammatory response against biofilm bacteria in chronic wounds. Wound Repair Regen., 2011, 19(3), 387-91.
297. Thurlow, L. R.; Hanke, M. L.; Fritz, T.; Angle, A.; Aldrich, A.; Williams, S. H.; Engebretsen, I. L.; Bayles, K. W.; Horswill, A. R.; Kielian, T. Staphylococcus aureus biofilms prevent macrophage phagocytosis and attenuate inflammation in vivo. J. Immunol., 2011, 186(11), 6585-96.
298. Percival, S. L.; Hill, K. E.; Williams, D. W.; Hooper, S. J.; Thomas, D. W.; Costerton, J. W. A review of the scientific evidence for biofilms in wounds. Wound Repair Regen., 2012, 20(5), 647-57.
299. Thomson, C. H. Biofilms: do they affect wound healing? Int. Wound J., 2011, 8(1), 63-7.
300. Kanno, E.; Kawakami, K.; Ritsu, M.; Ishii, K.; Tanno, H.; Toriyabe, S.; Imai, Y.; Maruyama, R.; Tachi, M. Wound healing in skin promoted by inoculation with Pseudomonas aeruginosa PAO1: The critical role of tumor necrosis factor-alpha secreted from infiltrating neutrophils. Wound Repair Regen., 2011, 19(5), 608-21.
301. Kanno, E.; Kawakami, K.; Miyairi, S.; Tanno, H.; Otomaru, H.; Hatanaka, A.; Sato, S.; Ishii, K.; Hayashi, D.; Shibuya, N.; Imai, Y.; Gotoh, N.; Maruyama, R.; Tachi, M. Neutrophil-derived tumor necrosis factor-alpha contributes to acute wound healing promoted by N-(3-oxododecanoyl)-L-homoserine lactone from Pseudomonas aeruginosa. J. Dermatol. Sci., 2013, 70(2), 130-8.
302. Percival, S. L.; Thomas, J. G.; Williams, D. W. Biofilms and bacterial imbalances in chronic wounds: anti-Koch. Int. Wound J., 2010, 7(3), 169-75.
303. Roy, S.; Elgharably, H.; Sinha, M.; Ganesh, K.; Chaney, S.; Mann, E.; Miller, C.; Khanna, S.; Bergdall, V. K.; Powell, H. M.; Cook, C. H.; Gordillo, G. M.; Wozniak, D. J.; Sen, C. K. Mixed-species biofilm compromises wound healing by disrupting epidermal barrier function. J. Pathol., 2014, 233(4), 331-43.
304. ECDC Healthcare-Associated Infections: Available from: http://www. ecdc. europa. eu/en/healthtopics/healthcareassociated_ infections/pages/index. aspx (Accessed Feb 13, 2015).
305. Allegranzi, B.; Nejad, B. S.; Combescure, C.; Graafmans, W.; Attar, H.; Donaldson, L.; Pittet, D. Burden of endemic health-care associated infection in developing countries: systematic review and metaanalysis. Lancet, 2011, 377(9761): 228-41.
306. World Health Organization. Health Care Associated Infections. Fact Sheet: Available from: http://www. who. int/gpsc/country_work/gpsc_ccisc_fact_sheet_en. pdf (Accessed Feb 13, 2015).
307. Donlan, R. M. Biofilms and device-associated infections. Emerg. Infect. Dis., 2001, 7(2), 277-81.
308. Revdiwala, S.; Rajdev, B. M.; Mulla, S. Characterization of bacterial etiologic agents of biofilm formation in medical devices in critical care setup. Crit. Care Res. Pract., 2012, 2012, 945805.
309. Zimmerli, W.; Lew, P. D.; Waldvogel, F. A. Pathogenesis of foreign body infection. Evidence for a local granulocyte defect. J. Clin. Invest., 1984, 73(4), 1191-200.
310. Otto, M. Staphylococcus epidermidis-the 'accidental' pathogen. Nat. Rev. Microbiol., 2009, 7(8), 555-67.
311. Fey, P. D.; Olson, M. E. Current concepts in biofilm formation of Staphylococcus epidermidis. Future Microbiol., 2010, 5(6), 917-33.
312. Holban, A. M.; Gestal, M. C.; Grumezescu, A. M. New molecular strategies for reducing implantable medical devices associated infections. Curr. Med. Chem., 2014, 21(29), 3375-82.
313. Pendleton, J. N.; Gorman, S. P.; Gilmore, B. F. Clinical relevance of the ESKAPE pathogens. Expert Rev. Anti Infect. Ther., 2013, 11(3), 297-308.
314. European Centre for Disease Prevention and Control. Annual Epidemiological Report on Communicable Diseases in Europe 2010. Stockholm: ECDC; 2010: Available from: http://www. ecdc. europa. eu/en/publications/Publications/1011_SUR_Annual_Epide miological_Report_on_Communicable_Diseases_in_Europe. pdf (Accessed Feb 8, 2015).
315. European Centre for Disease Prevention and Control. Technical Report. The Bacterial Challenge: Time to React. A Call to Narrow the Gap between Multidrug-Resistant Bacteria in the EU and the Development of New Antibacterial Agents. Stockholm: ECDC; 2009: Available from: http://www. ecdc. europa. eu/en/publications/Publications/0909_TER_The_Bacterial_Challenge_Ti me_to_React. pdf (Accessed Feb 8, 2015).
316. Infectious Diseases Society of America. Bad Bugs, No Drugs. As Antibiotic Discovery Stagnates. A Public Health Crisis Brews: Available from: http://www. fda. gov/ohrms/dockets/dockets/04s0233/04s-0233-c000005-03-IDSA-vol1. pdf (Accessed Feb 8, 2015).
317. Sohail, M. R.; Henrikson, C. A.; Braid-Forbes, M. J.; Forbes, K. F.; Lerner, D. J. Mortality and cost associated with cardiovascular implantable electronic device infections. Arch. Intern. Med., 2011, 171(20), 1821-8.
318. Stickler, D. J. Bacterial biofilms in patients with indwelling urinary catheters. Nat. Clin. Pract. Urol., 2008, 5(11), 598-608.
319. Hola, V.; Ruzicka, F. In: Urinary tract infections; Teneke Peter, Ed.; InTech, 2011; Vol. 1, pp. 153-72.
320. Stoodley, P.; Kathju, S.; Hu, F. Z.; Erdos, G.; Levenson, J. E.; Mehta, N.; Dice, B.; Johnson, S.; Hall-Stoodley, L.; Nistico, L.; Sotereanos, N.; Sewecke, J.; Post, J. C.; Ehrlich, G. D. Molecular and imaging techniques for bacterial biofilms in joint arthroplasty infections. Clin. Orthop. Relat. Res., 2005, (437), 31-40.
321. Johannsson, B.; Taylor, J.; Clark, C. R.; Shamsuddin, H.; Beekmann, S. E.; Polgreen, P.; Infectious Diseases Society of America Emerging Infections, N. Treatment approaches to prosthetic joint infections: results of an Emerging Infections Network survey. Diagn. Microbiol. Infect. Dis., 2010, 66(1), 16-23.
322. Cataldo, M. A.; Petrosillo, N.; Cipriani, M.; Cauda, R.; Tacconelli, E. Prosthetic joint infection: recent developments in diagnosis and management. J. Infect., 2010, 61(6), 443-8.
323. Stensballe, J.; Tvede, M.; Looms, D.; Lippert, F. K.; Dahl, B.; Tonnesen, E.; Rasmussen, L. S. Infection risk with nitrofurazoneimpregnated urinary catheters in trauma patients: a randomized trial. Ann. Intern. Med., 2007, 147(5), 285-93.
324. Reid, G. Biofilms in infectious disease and on medical devices. Int. J. Antimicrob. Agents, 1999, 11(3-4), 223-6; discussion 237-9.
325. Justo, J. A.; Bookstaver, P. B. Antibiotic lock therapy: review of technique and logistical challenges. Infect. Drug Resist., 2014, 7, 343-63.
326. O'Connell, H. A.; Kottkamp, G. S.; Eppelbaum, J. L.; Stubblefield, B. A.; Gilbert, S. E.; Gilbert, E. S. Influences of biofilm structure and antibiotic resistance mechanisms on indirect pathogenicity in a model polymicrobial biofilm. Appl. Environ. Microbiol., 2006, 72(7), 5013-9.
327. Istrate, C. M.; Holban, A. M.; Grumezescu, A. M.; Mogoanta, L.; Mogosanu, G. D.; Savopol, T.; Moisescu, M.; Iordache, M.; Vasile, B. S.; Kovacs, E. Iron oxide nanoparticles modulate the interaction of different antibiotics with cellular membranes. Rom. J. Morphol. Embryol., 2014, 55(3), 849-56.
328. Kolenbrander, P. E.; Andersen, R. N.; Blehert, D. S.; Egland, P. G.; Foster, J. S.; Palmer, R. J. Jr. Communication among oral bacteria. Microbiol. Mol. Biol. Rev., 2002, 66(3): 486-505.